Reversal of severe graft-versus-host disease after nonmyeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cells.
Khan
S A
SA
Moreb
J S
JS
D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells / Q000166:cytology; D003520:Cyclophosphamide / Q000494:pharmacology; D018450:Disease Progression; D005260:Female; D006086:Graft vs Host Disease / Q000628:therapy*; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D017404:In Situ Hybridization, Fluorescence; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy; D012074:Remission Induction; D033581:Stem Cell Transplantation / Q000379:methods*; D013234:Stem Cells / Q000166:cytology*; D013256:Steroids / Q000494:pharmacology; D013997:Time Factors; D018183:Transplantation Chimera; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous
D007166:Immunosuppressive Agents; D013256:Steroids; D003520:Cyclophosphamide